| Sandoz Pharmaceuticals AG - Rivastigmin Patch Sandoz eco 4,6 mg/24 h (9mg), transdermale Pflaster |
| 70340 | | 01 | | Rivastigmin Patch Sandoz eco 4,6 mg/24 h (9mg) | | transdermale Pflaster | | N06DA03 | | Rivastigmin | | 16.04.2026 | | |
|
| Composition |
| rivastigminum 9 mg, acidi acrylici et acrylates polymerisatum, ammonio methacrylatis copolymerum B, acrylates polymerisatum, Trägermaterial: poly(ethylenis terephthalas), Drucktinte (Schwarz): ad praeparationem pro 5.25 cm² cum liberatione 4.6 mg/24h. |
| Packungsbestandteile |
| Timbre transdermique | | | | Principe actif | Concentr. |
|---|
| Rivastigmine | 9 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acidi Acrylici | | | | Acrylates Polymerisatum | | | | Ammonio Methacrylatis Copolymerum B | | | | Cum Liberatione | 4.6mg / 24h | | | Drucktinte (Schwarz): ad Praeparationem | 5.25 cm | | | Poly(Ethylenis Terephthalas) | | Trägermaterial |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 | | | B | | Oui |
|
